Advertisement

Pharmaceutical Chemistry Journal

, Volume 5, Issue 2, pp 65–75 | Cite as

Dependence of the pharmacological activity on the structural peculiarities of derivatives of diarylaliphatic acids

  • S. S. Liberman
  • L. N. Yakhontov
Search for New Drugs
  • 10 Downloads

Keywords

Organic Chemistry Pharmacological Activity Structural Peculiarity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    M. Ya. Mikhel'son and É. V. Zeimal, Acetylcholine [in Russian]. Leningrad (1970).Google Scholar
  2. 2.
    V. M. Avakyan, Farmakol. i Toksikol., No. 1, 20 (1959).Google Scholar
  3. 3.
    U. Salow, Klin. Wschr.,15, 1405 (1936).Google Scholar
  4. 4.
    S. S. Liberman, Farmakol. i Toksikol., No. 6, 18 (1950).Google Scholar
  5. 5.
    A. S. Kucheruk, Ibid., No. 6, 706 (1961).Google Scholar
  6. 6.
    E. E. Mikhlina et al., Khimikofarm. Zh., No. 4, 27 (1968).Google Scholar
  7. 7.
    A. L. Midzhoyan (Ed.), Arpenal and Experience in Its Clinical Application [in Russian], Erevan (1964).Google Scholar
  8. 8.
    N. P. Denisenko, Author's Abstract of Dissertation [in Russian], Leningrad (1962).Google Scholar
  9. 9.
    S. S. Liberman, Farmakol. i Toksikol., No. 10, 10 (1956).Google Scholar
  10. 10.
    J. Chen et al., J. Pharmacol. Exp. Ther.,104, 269 (1952).Google Scholar
  11. 11.
    M. D. Mashkovskii, Farmakol. i Toksikol., No. 3, 3 (1963).Google Scholar
  12. 12.
    E. V. Chaikovskaya, in: New Drugs in Experiment and Clinic [in Russian] (1958), p. 153.Google Scholar
  13. 13.
    R. Nador, Progress in Drug Res.,2, 297 (1960).Google Scholar
  14. 14.
    M. D. Mashkovskii, Drugs [in Russian], Vol. 1 (1967).Google Scholar
  15. 15.
    P. Acred et al., Brit. J. Pharmacol.,12, 447 (1957).Google Scholar
  16. 16.
    M. Winbury et al., Arch. Int. Pharmacodyn.,97, 2 (1954).Google Scholar
  17. 17.
    L. Randall et al., J. Pharmacol. Exp. Ther.,104, 284 (1952).Google Scholar
  18. 18.
    L. Sternbach and S. Kaiser, J. Am. Chem. Soc.,75, 6068 (1953).Google Scholar
  19. 19.
    M. Protian and E. Adlerova, Chimia,12, 145 (1958).Google Scholar
  20. 20.
    Funcke et al., Arzneimittel-Forsch.,4, 492 (1954).Google Scholar
  21. 21.
    L. Tripod, Helv. Physiol. Pharmacol. Acta.,7, 135 (1949).Google Scholar
  22. 22.
    Z. Votava et al., in: Pharmacotherapeutica Praha (1961), p. 307.Google Scholar
  23. 23.
    Th. Wagner-Jauregg, Ber. Dtsch. Chem. Ges.,72, 1551 (1939).Google Scholar
  24. 24.
    R. Hazard et al., C. R. Soc. Biol.,144, 636 (1949).Google Scholar
  25. 25.
    A. Lands, J. Pharmacol. Exp. Ther.,102, 219 (1951).Google Scholar
  26. 26.
    A. Lands and F. Luduend, Ibid.,117, 331 (1956).Google Scholar
  27. 27.
    S. S. Liberman, Farmakol. i Toksikol., No. 6, 670 (1961).Google Scholar
  28. 28.
    M. D. Mashkovskii, K. A. Zaitseva, and L. N. Gerchikov, Med. Prom. SSSR, No. 5, 56 (1966).Google Scholar
  29. 29.
    M. D. Mashkovskii and K. A. Zaitseva, Byul. Éksperim. Biol. i Med., No. 1, 56 (1966).Google Scholar
  30. 30.
    L. N. Gerchikov and M. D. Mashkovskii, Farmakol. i Toksikol., No. 1, 31 (1966).Google Scholar
  31. 31.
    M. D. Mashkovskii and S. S. Liberman, Ibid., No. 4, 42 (1957).Google Scholar
  32. 32.
    V. D. Troshin and N. N. Akatova, in: Modern Problems of the Treatment of Nervous Diseases [in Russian], Gor'kii (1958), p. 60.Google Scholar
  33. 33.
    S. V. Bazanova, Sov. Med., No. 8, 122 (1957).Google Scholar
  34. 34.
    N. A. Bogoslovskaya, in: Chest Pain and Myocardial Infarct [in Russian], Gor'kii (1960), p. 209.Google Scholar
  35. 35.
    Yu. G. Mitirev, Klin. Med., No. 5, 138 (1958).Google Scholar
  36. 36.
    M. L. Gorinshtein and A. M. Kulik, Ter. Arkh.,2, 114 (1963).Google Scholar
  37. 37.
    K. D. Chaika, Sov. Med., No. 3, 21 (1962).Google Scholar
  38. 38.
    I. N. Rembez, Akush. i Gin., No. 2, 54 (1960).Google Scholar
  39. 39.
    S. S. Liberman et al., Khim-Farm. Zh., No. 1, 9 (1970).Google Scholar
  40. 40.
    M. D. Mashkovskii and K. A. Zaitseva, Farmakol. i Toksikol., No. 1, 36 (1967).Google Scholar
  41. 41.
    A. L. Mndzhoyan, Izv. AN Armyansk SSR, No. 12, 3 (1962).Google Scholar
  42. 42.
    S. S. Liberman, Esters of Diphenylacetic Acid and Its Derivatives as a New Class of Drugs. Author's Abstract of Doctoral Dissertation [in Russian], Moscow (1964).Google Scholar
  43. 43.
    L. Cook et al., J. Pharmacol. Exp. Ther. (1954).Google Scholar
  44. 44.
    D. Bovet et al., Helv. Physiol. Pharmacol. Acta.,14, 430 (1956).Google Scholar
  45. 45.
    A. A. Gavrilyuk, Farmakol. i Toksikol., No. 4, 428 (1961).Google Scholar
  46. 46.
    L. M. Rel', Vestn. Oftal'mol., No. 3, 51 (1960).Google Scholar
  47. 47.
    F. Blicke et al., J. Am. Chem. Soc.,66, 1645 (1944), p. 1087.Google Scholar
  48. 48.
    L. Abood, Arch. Int. Pharmacodyn,2, 186 (1959).Google Scholar
  49. 49.
    M. D. Mashkovskii and S. S. Liberman, Farmakol. i Toksikol., No. 3, 216 (1959).Google Scholar
  50. 50.
    S. S. Liberman, Med. Prom. SSSR, No. 5, 40 (1961).Google Scholar
  51. 51.
    E. N. Meshalkin, Khirurgiya, No. 1, 59 (1958).Google Scholar
  52. 52.
    A. N. Kabanov, Ibid., No. 6, 46 (1959).Google Scholar
  53. 53.
    Z. I. Kazanskii et al., Ibid., No. 10, 101 (1960).Google Scholar
  54. 54.
    A. Z. Manevich et al., Klin. Med., No. 11, 99 (1963).Google Scholar
  55. 55.
    Yu. I. Fishzon-Ryss, Ter. Arkh.,5, 15 (1969).Google Scholar
  56. 56.
    L. S. Rozenshtraukh and N. A. Rabukhina, Vestn. Rentgenol., No. 4, 25 (1966).Google Scholar
  57. 57.
    G. I. Varnovitsii and V. V. Vinogradov, Klin, Med., No. 12, 82 (1960).Google Scholar
  58. 58.
    M. Protiva and E. Adlerova, Coll. Czechoslov, Chem. Commun.,22, 1066 (1957).Google Scholar
  59. 59.
    A. Funce et al., Arzheimittel-Forsch.,9, 573 (1959).Google Scholar
  60. 60.
    L. Weaver et al., Arch. Int. Pharmacodyn,121, 415 (1959).Google Scholar
  61. 61.
    J. Levy et al., C. R. Soc. Biol.,142, 56 (1948).Google Scholar
  62. 61a.
    B. Lebovits et al., Arch. Gener. Psychiat.,7, 39 (1962).Google Scholar
  63. 62.
    A. Lands et al., J. Pharmacol. Exp. Ther.,100, 19 (1950).Google Scholar
  64. 63.
    S. S. Liberman and A. I. Polezhaeva, Farmakol. i Toksikol., No. 6, 656 (1963).Google Scholar
  65. 64.
    S. S. Liberman, Ibid., No. 6, 68 (1968).Google Scholar
  66. 65.
    M. D. Mashkovskii and S. S. Liberman, Ibid, No. 13, No. 6, 20 (1950).Google Scholar
  67. 66.
    S. S. Liberman, Med. Prom. SSSR, No. 6, 43 (1957).Google Scholar
  68. 67.
    L. P. Konyushevskii, in: Collection of Scientific Works of Krasnoyarsk Med. Institute [in Russian], Vol. 4 (1955), p. 72.Google Scholar
  69. 68.
    P. A. Pavlenko, Sov. Med., No. 10, 105 (1961).Google Scholar
  70. 69.
    A. M. Kats, in: The Pharmacology of New Sedatives and Their Clinical Application [in Russian] (1962), p. 83.Google Scholar
  71. 70.
    A. M. Kats, in: The Selective Action of Drugs on the Central Nervous System [in Russian], Leningrad (1958), p. 151.Google Scholar
  72. 71.
    M. Parkes, Brit. J., Pharmacol.,10, 95 (1955).Google Scholar
  73. 72.
    Z. Votava et al., Farmakol. i Toksikol., No. 3, 211 (1959).Google Scholar
  74. 73.
    R. Meier and K. Hoffmann, Helv. Med. Acta.,4, 106 (1941).Google Scholar
  75. 74.
    A. Phillips et al., J. Am. Chem. Soc.,144, 339 (1950).Google Scholar
  76. 75.
    J. Levy and B. Tchonbar, C. R. Soc. Biol.,76, 1955 (1954).Google Scholar
  77. 76.
    M. Negwer, Organish-Chemische Arzneimittel und ihre Synonyma, Berlin (1967).Google Scholar

Copyright information

© Consultants Bureau, a division of Plenum Publishing Corporation 1971

Authors and Affiliations

  • S. S. Liberman
    • 1
  • L. N. Yakhontov
    • 1
  1. 1.S. Ordzhonikidze All-Union Scientific-Research Institute of Pharmaceutical ChemistryMoscow

Personalised recommendations